Stories by Linda A. Johnson

Thursday, Nov. 26, 2015

Turing won't cut its $750-per-pill price

TRENTON, N.J. - After weeks of criticism from patients, doctors and other drugmakers for raising a life-saving medicine's price more than fifty-fold, Turing Pharmaceuticals is reneging on its ...
By Linda A. Johnson

Thursday, Nov. 5, 2015

Pfizer boosts patient income limit for free drug program

TRENTON, N.J. - As the furor over soaring U.S. prescription drug prices escalates and outrageous price increases by several smaller drugmakers give the entire industry a black eye, the biggest U.S.
By Linda A. Johnson

Thursday, Oct. 29, 2015

Pfizer, Allergan in early talks

TRENTON, N.J. - Pfizer and Botox maker Allergan are discussing a potential deal that could be the biggest of 2015, a year marked by a rapid-fire pace of megadeals, particularly in health care.
By Linda A. Johnson

Wednesday, March 25, 2015

Research on rare disease drugs increases

TRENTON, N.J. - The global pharmaceutical industry is pouring billions of dollars into developing treatments for rare diseases, which once drew little interest from major drugmakers.
By Linda A. Johnson

Monday, Nov. 24, 2014

Health care M&A leads global deal surge

As drugmakers and hospitals cut costs and sharpen focus, health care deals lead global surge.
By Linda A. Johnson

Tuesday, May 6, 2014

Bayer to buy Merck's consumer care business

TRENTON, N.J. - Germany's Bayer plans to buy U.S.-based Merck & Co.'s consumer health business, creating a combined medicine cabinet from aspirin to allergy pills.
By Linda A. Johnson

Friday, April 25, 2014

Smartphone apps remind patients to take their meds

Medicine only helps if you take it properly. And adhering to an exact schedule of what to take, and when, can be challenging for patients who are forgetful or need to take several medications.
By Linda A. Johnson

Wednesday, April 2, 2014

FDA OKs tablet for seasonal allergies

TRENTON, N.J. - The Food and Drug Administration said Wednesday that it has approved the first tablet in the U.S. for gradually reducing hay fever symptoms, an alternative to months of weekly ...
By Linda A. Johnson

Monday, May 27, 2013

Valeant to buy Bausch + Lomb

Canadian drugmaker Valeant Pharmaceuticals said Monday that it will pay $8.7 billion to buy Bausch + Lomb, one of the world's best-known makers of contact lenses, in a massive expansion of ...
By Linda A. Johnson

Monday, March 25, 2013

Johnson & Johnson recalls blood sugar meters

OneTouch VerioIQ blood glucose meters sold in the U.S. and other countries are being recalled because when a diabetic's blood sugar level is dangerously high, they do not provide a warning and ...
By Linda A. Johnson

Saturday, Nov. 24, 2012

Black Friday sales decline

Thanksgiving shopping took a noticeable bite out of Black Friday's start to the holiday season, as the latest survey found retail sales in stores fell slightly from last year.
By Linda A. Johnson

Friday, Nov. 23, 2012

Generic Lipitor recalled

TRENTON, N.J. - Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass particles.
By Linda A. Johnson

Wednesday, Oct. 5, 2011

Congressman investigates sellers on drug shortages

TRENTON, N.J. - A congress­man investigating worsening shortages of hospital drugs is demanding that secondary drug distributors reveal where they're getting scarce, lifesaving medicines - ...
By Linda A. Johnson
Search Augusta jobs